About GeneSys

GeneSys Biologics, established in 2014, is a privately held clinical-stage biotechnology company headquartered in Hyderabad, India. Our mission is to “expand patient access to essential medicines” by providing high-quality, safe, effective and affordable insulin biosimilars across the globe.

GeneSys key management and expert team brings extensive specialized experience and consists of successful scientists with exceptional scientific capabilities, advanced proficiency in clonal development, bioprocess sciences, in-depth knowledge on characterization analytics, bio-process technology transfer, quality assurance and global regulatory (US, EU, Rest of World) knowledge.

Shared expertise of our core team is the critical foundation for GeneSys.